Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Health‐related quality of life · participants with gallstone disease (cholesterol, pigment, or mixed) Modified dietary fat intake for treatment of gallstone disease in people of any age (2024) · Cochrane | no estimate extracted | NR | No studies |
Infliximab vs purine analogues Loss of clinical response · Crohn's disease patients (in remission at baseline) Infliximab for maintenance of medically‐induced remission in Crohn's disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Infliximab vs purine analogues Withdrawal due to adverse events · Crohn's disease patients (in remission at baseline) Infliximab for maintenance of medically‐induced remission in Crohn's disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous CT‐P13 and purine analogues vs intravenous CT‐P13 and purine analogues Serious adverse events · patients with Crohn's disease (active disease population with clinical response at baseline) Infliximab for maintenance of medically‐induced remission in Crohn's disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Infliximab vs adalimumab Clinical relapse · patients with Crohn's disease (active disease population with clinical response at baseline) Infliximab for maintenance of medically‐induced remission in Crohn's disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Infliximab combined with purine analogues vs purine analogues Loss of clinical response · Crohn's disease patients (in remission at baseline) Infliximab for maintenance of medically‐induced remission in Crohn's disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Infliximab vs purine analogues Clinical relapse · Crohn's disease patients (in remission at baseline) Infliximab for maintenance of medically‐induced remission in Crohn's disease (2024) · Cochrane | no estimate extracted | NR | No studies |
Alpha‐lipoic acid vs placebo Change in any validated quality of life score · people with DPN Alpha‐lipoic acid for diabetic peripheral neuropathy (2024) · Cochrane | no estimate extracted | NR | No studies |
Alpha‐lipoic acid vs placebo Complications of DPN · people with DPN Alpha‐lipoic acid for diabetic peripheral neuropathy (2024) · Cochrane | no estimate extracted | NR | No studies |
Manual therapy, prescribed exercises or both vs minimal or no intervention Proportion with a serious adverse event · lateral elbow pain Manual therapy and exercise for lateral elbow pain (2024) · Cochrane | no estimate extracted | NR | No studies |
Manual therapy, prescribed exercises or both vs placebo Quality of life · lateral elbow pain Manual therapy and exercise for lateral elbow pain (2024) · Cochrane | no estimate extracted | NR | No studies |
Manual therapy, prescribed exercises or both vs placebo Participant‐reported treatment success · lateral elbow pain Manual therapy and exercise for lateral elbow pain (2024) · Cochrane | no estimate extracted | NR | No studies |
Manual therapy, prescribed exercises or both vs placebo Proportion of withdrawals · lateral elbow pain Manual therapy and exercise for lateral elbow pain (2024) · Cochrane | no estimate extracted | NR | No studies |
Manual therapy, prescribed exercises or both vs placebo Proportion with adverse events · lateral elbow pain Manual therapy and exercise for lateral elbow pain (2024) · Cochrane | no estimate extracted | NR | No studies |
Manual therapy, prescribed exercises or both vs placebo Proportion with a serious adverse event · lateral elbow pain Manual therapy and exercise for lateral elbow pain (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Sexual quality of life · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Prostate‐related events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Lower urinary tract symptoms · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs PDE5I Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs PDE5I Treatment withdrawal due to adverse events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs PDE5I Lower urinary tract symptoms · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone as an add‐on to PDE5I vs PDE5I alone Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone as an add‐on to PDE5I vs PDE5I alone Lower urinary tract symptoms · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB All‐cause mortality ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB Health‐related quality of life ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB All‐cause mortality start of surgery ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB Health‐related quality of life ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs mechanical thrombectomy Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs mechanical thrombectomy Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs pulse spray technique Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs pulse spray technique Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs continuous infusion Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs continuous infusion Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs continuous infusion Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs pulse spray technique Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs continuous infusion Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Mechanical thrombectomy vs continuous infusion Death · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs continuous infusion Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs continuous infusion Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs continuous infusion Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs continuous infusion Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs pulse spray technique Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical thrombectomy vs continuous infusion Death · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Continuous Infusion vs pulse spray technique Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Continuous Infusion vs pulse spray technique Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Continuous Infusion vs pulse spray technique Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Continuous Infusion vs pulse spray technique Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Continuous Infusion vs pulse spray technique Death · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |
Pharmacomechanical thrombolysis (Cragg® catheter) vs pulse spray technique Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane | no estimate extracted | NR | No studies |